Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07089238 · ClinicalTrials.gov registry record · NA

Evaluate the Effects of Citicoline on Mood in Healthy Adults

A NA study of Healthy, sponsored by Kirin Holdings Company, Limited.

Recruiting
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT07089238: Recruiting NA study of Healthy, sponsored by Kirin Holdings Company, Limited.

NCT07089238 is a NA study of Healthy that is actively recruiting participants, run by Kirin Holdings Company, Limited. The registered enrollment target is 90 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07089238, a NA study of Healthy, is actively recruiting participants, sponsored by Kirin Holdings Company, Limited.

RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The objective of this trial is to determine the effects of citicoline on mood in healthy Men and Women compared to a placebo.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Citicoline

Study Locations (1)

Ohio

  • The Center for Applied Health Sciences - Canfield

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2025-07-31
Est. Completion 2026-03-31
Phase NA

Sponsor

Kirin Holdings Company, Limited

2 total trials

What the Registry Record Tells You About NCT07089238

The ClinicalTrials.gov registry entry for NCT07089238 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (86% lower). The listed sponsor is Kirin Holdings Company, Limited, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT07089238 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT07089238 about?

NCT07089238 is a clinical study titled "Evaluate the Effects of Citicoline on Mood in Healthy Adults". The objective of this trial is to determine the effects of citicoline on mood in healthy Men and Women compared to a placebo.

What is the current status of trial NCT07089238?

This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2025-07-31. Estimated completion is 2026-03-31.

What conditions does trial NCT07089238 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT07089238?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Citicoline (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07089238?

This trial is sponsored by Kirin Holdings Company, Limited, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07089238 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.